Back to Search
Start Over
Comment on the paper "Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results".
- Source :
-
PloS one [PLoS One] 2021 Feb 18; Vol. 16 (2), pp. e0245480. Date of Electronic Publication: 2021 Feb 18 (Print Publication: 2021). - Publication Year :
- 2021
-
Abstract
- Competing Interests: AM and SA are authors of the work disputed by Gandjour. Previous work related to the letter of Gandjour was financed by Gilead. Further study grants in the last five years were received from Abbvie, Janssen Cilag and Johnson & Johnson.
Details
- Language :
- English
- ISSN :
- 1932-6203
- Volume :
- 16
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- PloS one
- Publication Type :
- Academic Journal
- Accession number :
- 33600462
- Full Text :
- https://doi.org/10.1371/journal.pone.0245480